Literature DB >> 23645696

Phosphorylation of KRAB-associated protein 1 (KAP1) at Tyr-449, Tyr-458, and Tyr-517 by nuclear tyrosine kinases inhibits the association of KAP1 and heterochromatin protein 1α (HP1α) with heterochromatin.

Sho Kubota1, Yasunori Fukumoto, Kazumasa Aoyama, Kenichi Ishibashi, Ryuzaburo Yuki, Takao Morinaga, Takuya Honda, Noritaka Yamaguchi, Takahisa Kuga, Takeshi Tomonaga, Naoto Yamaguchi.   

Abstract

Protein tyrosine phosphorylation regulates a wide range of cellular processes at the plasma membrane. Recently, we showed that nuclear tyrosine phosphorylation by Src family kinases (SFKs) induces chromatin structural changes. In this study, we identify KRAB-associated protein 1 (KAP1/TIF1β/TRIM28), a component of heterochromatin, as a nuclear tyrosine-phosphorylated protein. Tyrosine phosphorylation of KAP1 is induced by several tyrosine kinases, such as Src, Lyn, Abl, and Brk. Among SFKs, Src strongly induces tyrosine phosphorylation of KAP1. Nucleus-targeted Lyn potentiates tyrosine phosphorylation of KAP1 compared with intact Lyn, but neither intact Fyn nor nucleus-targeted Fyn phosphorylates KAP1. Substitution of the three tyrosine residues Tyr-449/Tyr-458/Tyr-517, located close to the HP1 binding-motif, into phenylalanine ablates tyrosine phosphorylation of KAP1. Immunostaining and chromatin fractionation show that Src and Lyn decrease the association of KAP1 with heterochromatin in a kinase activity-dependent manner. KAP1 knockdown impairs the association of HP1α with heterochromatin, because HP1α associates with KAP1 in heterochromatin. Intriguingly, tyrosine phosphorylation of KAP1 decreases the association of HP1α with heterochromatin, which is inhibited by replacement of endogenous KAP1 with its phenylalanine mutant (KAP1-Y449F/Y458F/Y517F, KAP1-3YF). In DNA damage, KAP1-3YF repressed transcription of p21. These results suggest that nucleus-localized tyrosine kinases, including SFKs, phosphorylate KAP1 at Tyr-449/Tyr-458/Tyr-517 and inhibit the association of KAP1 and HP1α with heterochromatin.

Entities:  

Keywords:  HP1; Heterochromatin; KAP1; Nucleus; Protein Phosphorylation; Protein-Protein Interactions; Tyrosine Protein Kinase (Tyrosine Kinase)

Mesh:

Substances:

Year:  2013        PMID: 23645696      PMCID: PMC3682585          DOI: 10.1074/jbc.M112.437756

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  c-Src but not Fyn promotes proper spindle orientation in early prometaphase.

Authors:  Yuji Nakayama; Yuki Matsui; Yumi Takeda; Mai Okamoto; Kohei Abe; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

3.  The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.

Authors:  Yuuki Obata; Yasunori Fukumoto; Yuji Nakayama; Takahisa Kuga; Naoshi Dohmae; Naoto Yamaguchi
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

4.  Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization.

Authors:  Akinori Takahashi; Yuuki Obata; Yasunori Fukumoto; Yuji Nakayama; Kousuke Kasahara; Takahisa Kuga; Yukihiro Higashiyama; Takashi Saito; Kazunari K Yokoyama; Naoto Yamaguchi
Journal:  Exp Cell Res       Date:  2009-02-23       Impact factor: 3.905

5.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

6.  Nuclear ErbB4 signaling through H3K9me3 is antagonized by EGFR-activated c-Src.

Authors:  Kenichi Ishibashi; Yasunori Fukumoto; Hitomi Hasegawa; Kohei Abe; Shoichi Kubota; Kazumasa Aoyama; Sho Kubota; Yuji Nakayama; Naoto Yamaguchi
Journal:  J Cell Sci       Date:  2012-12-10       Impact factor: 5.285

7.  Molecular mechanism of the impairment in activation signal transduction in CD4(+) T cells from old mice.

Authors:  T Tamura; T Kunimatsu; S T Yee; O Igarashi; M Utsuyama; S Tanaka; S i Miyazaki; K Hirokawa; H Nariuchi
Journal:  Int Immunol       Date:  2000-08       Impact factor: 4.823

8.  Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.

Authors:  J D Bjorge; C Bellagamba; H C Cheng; A Tanaka; J H Wang; D J Fujita
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

9.  Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity.

Authors:  Kikuko Ikeda; Yuji Nakayama; Yuuki Togashi; Yuuki Obata; Takahisa Kuga; Kousuke Kasahara; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  Exp Cell Res       Date:  2008-09-11       Impact factor: 3.905

10.  Association of the transcriptional corepressor TIF1beta with heterochromatin protein 1 (HP1): an essential role for progression through differentiation.

Authors:  Florence Cammas; Marielle Herzog; Thierry Lerouge; Pierre Chambon; Régine Losson
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

View more
  18 in total

Review 1.  Hsp90 in Cancer: Transcriptional Roles in the Nucleus.

Authors:  Stuart K Calderwood; Len Neckers
Journal:  Adv Cancer Res       Date:  2015-10-12       Impact factor: 6.242

2.  Src Acts as an Effector for Ku70-dependent Suppression of Apoptosis through Phosphorylation of Ku70 at Tyr-530.

Authors:  Mariko Morii; Sho Kubota; Takuya Honda; Ryuzaburo Yuki; Takao Morinaga; Takahisa Kuga; Takeshi Tomonaga; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

3.  Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.

Authors:  Yasunori Fukumoto; Mariko Morii; Takahito Miura; Sho Kubota; Kenichi Ishibashi; Takuya Honda; Aya Okamoto; Noritaka Yamaguchi; Atsushi Iwama; Yuji Nakayama; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

4.  Desuppression of TGF-β signaling via nuclear c-Abl-mediated phosphorylation of TIF1γ/TRIM33 at Tyr-524, -610, and -1048.

Authors:  Ryuzaburo Yuki; Takashi Tatewaki; Noritaka Yamaguchi; Kazumasa Aoyama; Takuya Honda; Sho Kubota; Mariko Morii; Ichiro Manabe; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  Oncogene       Date:  2018-09-03       Impact factor: 9.867

5.  Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix.

Authors:  Sho Kubota; Mariko Morii; Ryuzaburo Yuki; Noritaka Yamaguchi; Hiromi Yamaguchi; Kazumasa Aoyama; Takahisa Kuga; Takeshi Tomonaga; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2015-03-13       Impact factor: 5.157

6.  KAP1 phosphorylation promotes the survival of neural stem cells after ischemia/reperfusion by maintaining the stability of PCNA.

Authors:  Wan Wang; Tianqing Yan; Xinjian Guo; Heng Cai; Chang Liang; Linyan Huang; Yanling Wang; Ping Ma; Suhua Qi
Journal:  Stem Cell Res Ther       Date:  2022-07-07       Impact factor: 8.079

7.  Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage.

Authors:  Shoichi Kubota; Yasunori Fukumoto; Kenichi Ishibashi; Shuhei Soeda; Sho Kubota; Ryuzaburo Yuki; Yuji Nakayama; Kazumasa Aoyama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

Review 8.  KAPtain in charge of multiple missions: Emerging roles of KAP1.

Authors:  Chun-Ting Cheng; Ching-Ying Kuo; David K Ann
Journal:  World J Biol Chem       Date:  2014-08-26

9.  KAP1 is a Novel Substrate for the Arginine Methyltransferase PRMT5.

Authors:  Roberta di Caprio; Michela Ciano; Giorgia Montano; Paola Costanzo; Elena Cesaro
Journal:  Biology (Basel)       Date:  2015-01-09

Review 10.  TRIM28 as a novel transcriptional elongation factor.

Authors:  Heeyoun Bunch; Stuart K Calderwood
Journal:  BMC Mol Biol       Date:  2015-08-21       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.